Allergan (A Subsidiary of AbbVie Inc.), Viora and CANDELA CORPORATION are Dominating the Middle East and Africa Aesthetics Energy Based Device Market in 2019

Middle East and Africa Aesthetics Energy Based Device is expected to grow with the CAGR of 6.6% in the forecast period of 2020 to 2027. The years considered for study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/middle-east-and-africa-aesthetic-energy-based-device-market

Middle East and Africa aesthetics energy based device market is a highly consolidated market, which includes specific number of key players as well as local players. The market has witnessed increased strategic developments owing to favourable market scenario.

The major players dealing in Middle East and Africa aesthetics energy based device market are introducing strong range of product portfolio. This helped companies to maximize the sales with enhanced product portfolio. For instance, in July 2020, Venus Concept Inc. a global medical aesthetic technology leader announced that it has received FDA 510(k) clearance to market and sell Venus Viva MD. This shows that the company is constantly evolving with the innovation and technology in aesthetic markets.

Allergan (A Subsidiary of AbbVie Inc.) is the dominating player in Middle East and Africa aesthetics energy based device market. The other key players existing in the market Viora, CANDELA CORPORATION, Solta Medical (A Subsidiary of Bausch Health Companies Inc.), Fotona, Lumenis, Merz Pharma and Venus Concept, among others.

Middle East and Africa Aesthetics Energy Based Device Market

Allergan (A Subsidiary of AbbVie Inc.)

Allergan (A Subsidiary of AbbVie Inc.) is headquartered in Dublin, Ireland was founded in 2013. The company focused on the developing, manufacturing and commercializing branded pharmaceutical, device, surgical and regenerative medicine products for patients around the world. Company operates in medical aesthetics, eyes care, central nervous system, gastroenterology segments out of which medical aesthetics is the market focused segment.

  • In May 2020, Allergan (A Subsidiary of AbbVie Inc.) announced that AbbVie has now completed the acquisition of Allergan under a scheme of arrangement. This helps the company to expand its product portfolio of leading brands of aesthetics within the market.

The company has a wide global presence across Europe, Latin America, Asia-Pacific, South America, Middle East and Africa.

Viora

Viora is headquartered in New York, U.S. and was founded in year 1990. The company is focused to grow together with its customers by providing aesthetics technology. The company offers wide range of product categories such as vseries platform, handpeices and systems and all these are the market focused categories.

  • In October 2016, Viora was awarded by the Winner of Dermascope 2016- Aestheticians Choice. This shows that the company is growing with the choice of experts and physicians within the market.

The company has presence in Africa, Europe, Latin America, Asia-Pacific, South America and Middle East.

CANDELA CORPORATION

CANDELA CORPORATION is headquartered in Massachusetts, U.S. and was found in 1970. The company focuses on providing advanced energy-based solutions for a various medical-aesthetic applications including treatment of benign vascular and pigmented lesions, facial resurfacing, wrinkle reduction, body shaping, women's health, and tattoo and hair removal among more. Company operates in nordlys, gentle pro series, picoway, vbeam prima, profound, CO2RE Intima, Ydun, eTwo, CO2RE, VelaShape III, vbeam perfecta, sirius, elos plus, alex trivantage and exceed microneedling segments out of which nordlys, gentle pro series, picoway, vbeam prima, profound, CO2RE intima, Ydun, eTwo, CO2RE, velashape III and vbeam perfecta are the market focused category.

  • In 2020, CANDELA CORPORATION announced the clinical study of a laser-resistant port-wine stain (PWS) earlier treated with pulsed dye laser and highest spot size of 10 mm. Marked lightening of the PWS with no epidermal injury was seen in a skin type III male and laser-resistant PWS improvement in a skin type IV male, following 2 monthly Vbeam Prima treatments with the large 15 mm spot size. Larger spot size improves penetration and efficiency in the treatment of laser resistant port-wine stains. This study helps the company to establish beliefs among customers in the market.

The company has wide global presence in North America, Europe, Asia-Pacific, Middle East & Africa and South America.